{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:24:05Z","timestamp":1793229845402,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008245","name":"Center for Neuroscience Research","doi-asserted-by":"publisher","award":["10,29"],"award-info":[{"award-number":["10,29"]}],"id":[{"id":"10.13039\/100008245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.parkreldis.2025.107933","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:03:12Z","timestamp":1750939392000},"page":"107933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Regional neuromelanin reduction in the substantia nigra in different subtype of Parkinson's disease"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-228X","authenticated-orcid":false,"given":"Xiali","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-7674","authenticated-orcid":false,"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parkreldis.2025.107933_bib1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/acn3.51102","article-title":"Parkinson disease clinical subtypes: key features & clinical milestones","volume":"7","author":"Campbell","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107933_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107933_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease","volume":"76","author":"De Pablo-Fern\u00e1ndez","year":"2019","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107933_bib4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107933_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030551","article-title":"Parkinson's disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107933_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4103\/1673-5374.131583","article-title":"Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin","volume":"9","author":"Nakamura","year":"2014","journal-title":"Neural Regen Res"},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107933_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00702-020-02295-8","article-title":"Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease","volume":"128","author":"Wang","year":"2021","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2025.107933_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2016.12.036","article-title":"Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging","volume":"638","author":"Xiang","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107933_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/mds.28988","article-title":"Regional selectivity of neuromelanin changes in the substantia nigra in atypical parkinsonism","volume":"37","author":"Chougar","year":"2022","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107933_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/ene.13628","article-title":"Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes","volume":"25","author":"Wang","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107933_bib11","article-title":"Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI","volume":"14","author":"Gao","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.107933_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2025.107933_bib13","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jocn.2015.03.008","article-title":"Validation of the rapid eye movement sleep behavior disorder screening questionnaire in China","volume":"22","author":"Wang","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.parkreldis.2025.107933_bib14","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/acn3.51475","article-title":"Determinants of quality of life in Parkinson's disease: a perspective of novel clinical subtypes","volume":"8","author":"Fan","year":"2021","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2025.107933_bib15","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/brain\/awaa216","article-title":"Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease","volume":"143","author":"Biondetti","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2025.107933_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26653","article-title":"Anatomical and functional organization of the human substantia nigra and its connections","volume":"6","author":"Zhang","year":"2017","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107933_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease","volume":"76","author":"De Pablo-Fern\u00e1ndez","year":"2019","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107933_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41531-023-00466-4","article-title":"Two-year clinical progression in focal and diffuse subtypes of Parkinson's disease","volume":"9","author":"Johansson","year":"2023","journal-title":"npj Parkinson's Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107933_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mds.28321","article-title":"The pathophysiological correlates of Parkinson's disease clinical subtypes","volume":"36","author":"Belvisi","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2025.107933_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102111","article-title":"Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity","volume":"25","author":"Abbasi","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"9","key":"10.1016\/j.parkreldis.2025.107933_bib21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/mds.26199","article-title":"Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders","volume":"30","author":"Tremblay","year":"2015","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2025.107933_bib22","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2025.107933_bib23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2025.107933_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2018.04.022","article-title":"Motor asymmetry and neuromelanin imaging: concordance in Parkinson's disease","volume":"53","author":"Prasad","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.parkreldis.2025.107933_bib25","first-page":"421","article-title":"123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms","volume":"26","author":"Filippi","year":"2005"},{"issue":"8","key":"10.1016\/j.parkreldis.2025.107933_bib26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2967\/jnumed.110.076802","article-title":"Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET","volume":"51","author":"Yagi","year":"2010","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107933_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41531-025-00972-7","article-title":"High-resolution mapping of substantia nigra in Parkinson's disease using 7 tesla magnetic resonance imaging","volume":"11","author":"Madelung","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.107933_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0284185117722812","article-title":"Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and (123)I-FP-CIT SPECT","volume":"59","author":"Kuya","year":"2018","journal-title":"Acta Radiol"},{"key":"10.1016\/j.parkreldis.2025.107933_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.007","article-title":"Neuromelanin-sensitive MRI of the substantia nigra: an imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease","volume":"58","author":"Wang","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2025.107933_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","article-title":"Neuromelanin imaging and dopaminergic loss in Parkinson's disease","volume":"8","author":"Isaias","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107933_bib31","article-title":"Principal component analysis of multimodal neuromelanin MRI and dopamine transporter PET data provides a specific metric for the nigral dopaminergic neuronal density","volume":"11","author":"Finkelstein","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2025.107933_bib32","doi-asserted-by":"crossref","first-page":"1215505","DOI":"10.3389\/frdem.2023.1215505","article-title":"Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson\u2019s disease with freezing of gait","volume":"2","author":"Huddleston","year":"2023","journal-title":"Front Dement."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107933_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000522329","article-title":"Assessing mild cognitive impairment in Parkinson's disease by magnetic resonance quantitative susceptibility mapping combined voxel-wise and radiomic analysis","volume":"85","author":"Zhao","year":"2022","journal-title":"Eur. Neurol."},{"issue":"29","key":"10.1016\/j.parkreldis.2025.107933_bib34","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1523\/JNEUROSCI.0242-21.2021","article-title":"Substantia nigra integrity correlates with sequential working memory in Parkinson's disease","volume":"41","author":"Liu","year":"2021","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.107933_bib35","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.21037\/qims-23-1778","article-title":"A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease","volume":"14","author":"Hou","year":"2024","journal-title":"Quant. Imag. Med. Surg."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107933_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41531-024-00708-z","article-title":"Misfolded protein deposits in Parkinson's disease and Parkinson's disease-related cognitive impairment, a [(11)C]PBB3 study","volume":"10","author":"Matarazzo","year":"2024","journal-title":"npj Parkinson's Dis."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025006741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025006741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:15:21Z","timestamp":1762370121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802025006741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S1353802025006741"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107933","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional neuromelanin reduction in the substantia nigra in different subtype of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107933"}}